Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Alignment Healthcare, Inc. (ALHC)

6.99 -0.01 (-0.14%)
As of 9:56:23 AM EST. Market Open.
Trade ALHC on Coinbase
Chart Range Bar
Loading chart for ALHC
  • Previous Close 7.00
  • Open 7.02
  • Bid 5.20 x 200
  • Ask 8.94 x 200
  • Day's Range 6.90 - 7.02
  • 52 Week Range 6.01 - 25.12
  • Volume 272,420
  • Avg. Volume 8,326,817
  • Market Cap (intraday) 1.463B
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) 49.93
  • EPS (TTM) 0.14
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 10.79
  • Zacks Rating Bearish

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. Alignment Healthcare, Inc. was founded in 2013 and is based in Orange, California.

www.alignmenthealth.com

1,849

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Healthcare Plans

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ALHC
64.61%
S&P 500 (^GSPC)
10.48%

1-Year Return

ALHC
58.49%
S&P 500 (^GSPC)
10.38%

3-Year Return

ALHC
16.11%
S&P 500 (^GSPC)
73.53%

5-Year Return

ALHC
65.03%
S&P 500 (^GSPC)
62.28%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.36B
Earnings -8.05M
Profit Margin -0.59%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
-1.0%
0.0%
1.0%
2.0%

Analyst Insights

View More

Analyst Price Targets

8.00
10.79 Average
6.99 Current
17.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/2/2026
Analyst TD Cowen
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 12 -> 10

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.58%

  • Return on Assets (ttm)

    2.26%

  • Return on Equity (ttm)

    13.18%

  • Revenue (ttm)

    4.94B

  • Net Income Avi to Common (ttm)

    28.92M

  • Diluted EPS (ttm)

    0.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    742.95M

  • Total Debt/Equity (mrq)

    119.34%

  • Levered Free Cash Flow (ttm)

    77.02M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: